Tollin S R, Mery G M, Jelveh N, Fallon E F, Mikhail M, Blumenfeld W, Perlmutter S
Department of Medicine, Winthrop-University Hospital and The State University at New York at Stony Brook School of Medicine, Mineola, USA.
Thyroid. 2000 Mar;10(3):235-41. doi: 10.1089/thy.2000.10.235.
Fine-needle aspiration biopsy (FNAB) is a commonly performed procedure used in the evaluation of solitary thyroid nodules, in which the risk of malignancy is approximately 5% in most patients. Recently, the use of ultrasound (US) guidance in FNAB has been shown to enhance the diagnostic efficacy of this procedure. However, the risk of malignancy in thyroid nodules occurring within a multinodular goiter (MNG) has not been completely clarified, nor has the optimal means of investigating such nodules using FNAB.
We performed a retrospective study of all patients seen over a 4-year period with a MNG that had one or more nodules who underwent FNAB under US guidance. The results from the history and physical examination, thyroid function and antibody tests, radionuclide studies, thyroid sonogram, cytology of aspirated nodules, and surgical pathology were recorded and analyzed.
A total of 93 nodules were aspirated in 61 patients with MNG. Adequate material was obtained in 96% of aspirates on the first attempt. Sixty-seven aspirates in 44 patients yielded benign cytology and 22 aspirates in 15 patients yielded suspicious cytology. All patients with suspicious cytology underwent thyroid surgery. Thyroid cancer was found in 5 of these nodules, including 4 cases of papillary cancer and 1 case of Hürthle cell cancer, and 1 additional patient had occult papillary cancer discovered. The overall malignancy rate in thyroid nodules among the patients with MNG was approximately 5%.
FNAB under US guidance is a useful diagnostic modality in the evaluation of thyroid nodules in selected patients with MNG. Because the risk of thyroid malignancy in these nodules is comparable to that which exists in solitary thyroid nodules, the possibility of thyroid malignancy should be considered in all patients with MNG.
细针穿刺活检(FNAB)是评估甲状腺单发结节时常用的一项操作,大多数患者发生恶性病变的风险约为5%。近来,在FNAB中使用超声(US)引导已显示可提高该操作的诊断效能。然而,多结节性甲状腺肿(MNG)内出现的甲状腺结节发生恶性病变的风险尚未完全明确,使用FNAB检查此类结节的最佳方法也未明确。
我们对4年间所有因MNG且有一个或多个结节而接受US引导下FNAB的患者进行了一项回顾性研究。记录并分析了病史与体格检查、甲状腺功能及抗体检测、放射性核素检查、甲状腺超声检查、穿刺结节的细胞学检查以及手术病理检查的结果。
61例MNG患者共穿刺了93个结节。首次穿刺时96%的取材足够。44例患者的67次穿刺结果为良性细胞学表现,15例患者的22次穿刺结果为可疑细胞学表现。所有细胞学表现可疑的患者均接受了甲状腺手术。这些结节中有5个发现为甲状腺癌,包括4例乳头状癌和1例嗜酸性细胞癌,另有1例患者发现隐匿性乳头状癌。MNG患者甲状腺结节的总体恶性率约为5%。
US引导下的FNAB是评估部分MNG患者甲状腺结节的一种有用的诊断方法。由于这些结节中甲状腺恶性病变的风险与甲状腺单发结节的风险相当,所有MNG患者均应考虑甲状腺恶性病变的可能性。